ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $2,435,000 | -39.8% | 75,000 | -21.5% | 0.30% | -46.4% |
| Q1 2016 | $4,046,000 | +169.6% | 95,497 | +107.4% | 0.55% | +358.3% |
| Q1 2015 | $1,501,000 | -73.1% | 46,044 | -79.5% | 0.12% | -68.8% |
| Q3 2014 | $5,571,000 | +23.3% | 225,000 | +12.5% | 0.38% | +61.8% |
| Q2 2014 | $4,518,000 | +85.7% | 200,000 | +100.0% | 0.24% | +153.2% |
| Q1 2014 | $2,433,000 | -2.6% | 100,000 | 0.0% | 0.09% | -12.1% |
| Q4 2013 | $2,499,000 | -9.0% | 100,000 | 0.0% | 0.11% | -22.5% |
| Q3 2013 | $2,747,000 | -24.3% | 100,000 | -50.0% | 0.14% | -32.0% |
| Q2 2013 | $3,630,000 | – | 200,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |